Adapting Audits to meet the needs of the Pharmaceutical Industry Today


Within the pharmaceutical industry, there is a constant obligation to engage with supply chain members on matters concerning quality and so auditing remains a critical piece of the drug development and manufacturing process. Against a backdrop of scheduling challenges, remote audits present a viable solution to maintain the high level of focus on quality and compliance to mitigate current COVID-19 related issues and travel restrictions but also, looking ahead, to ensure supply chain visibility to meet future auditing requirements with increased agility.


In this white paper, Marine Certain, Audits Activity Business Development Manager, describes best practice for auditor/auditee collaboration for remote audits and key considerations for success.


Please complete the form below to access the white paper.